TaiMed Biologics Inc.

NT$55.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4147Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (11.90%)
Div yield —
ROE (3.66%)
Biotechnology
Beta (5Y) (0.01)
PE TTM —
TSR TTM (22.97%)
Mkt cap NT$15.03B
ROIC (2.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$70
26.99%
(43.70%)
Hold 10|12|11|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.18
1.14
1.19
1.33
10.17%
8.63%
18.09%
23.07%
RevenueNT$M
724.2
757.6
752.5
765.4
0.76%
7.86%
3.28%
6.80%
Peers (US$453.8M)
Cap (US$)
PE
465.7M
—
439.6M
29.51x
Capital
TTM
5Y
10Y
Leveragex
1.129
(1.114)
(0.856)
EBIT/Intx
0.975
0.402
0.344
Own earn%
20.82
(2.99)
15.73
Sh yield%
33.18
17.83
15.74
Owners
Insiders/Inst%
0.74
81.71
Short interest%
5.93
SBC / revenue%
3.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
18–23
$1 testx
0.7
Incr. ROIC%
7